Zydus Wellness Limited (IN:ZYDUSWELL)
:ZYDUSWELL
Want to see IN:ZYDUSWELL full AI Analyst Report?
ZYDUSWELL Stock Chart & Stats
₹424.90
-₹21.60(-1.10%)
At close: 4:00 PM EST
₹424.90
-₹21.60(-1.10%)
Day’s Range― - ―
52-Week Range₹357.55 - ₹552.40
Previous CloseN/A
Volume6.77K
Average Volume (3M)15.16K
Market Cap
₹161.07B
Enterprise Value₹63.18B
Total Cash (Recent Filing)₹1.48B
Total Debt (Recent Filing)₹30.42B
Price to Earnings (P/E)81.7
Beta0.81
Next Earnings
Jul 31, 2026EPS Estimate
4.3Next Dividend Ex-DateN/A
Dividend Yield0.28%
Share Statistics
EPS (TTM)30.39
Shares Outstanding318,160,700
10 Day Avg. Volume9,092
30 Day Avg. Volume15,161
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.33
Price to Sales (P/S)3.42
P/FCF Ratio345.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.43
Revenue Forecast (FY)₹53.51B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthA sustained +37.9% revenue acceleration in FY2026 indicates meaningful top-line momentum and expanding market penetration. For 2–6 months this supports scale benefits, bargaining power with channels, and opportunities to leverage fixed-cost absorption to restore margins if growth is maintained.
Diversified Wellness PortfolioA broad brand-led FMCH portfolio across nutrition, oral care, personal care and health foods provides structural resilience vs single-category risk. Diversification across categories and channels (general trade, modern trade, e‑commerce) supports durable revenue streams and sustained consumer demand.
Sizeable Equity CushionA large equity base gives financial flexibility to fund working-capital cycles, marketing spend and selective capex without immediate solvency stress. This buffer helps absorb shocks from temporary margin pressure and supports strategic investments over the next several months.
Bears Say
Margin CompressionA sharp net margin reset from ~12.8% to ~5.0% materially reduces returns on sales and limits internal funding capacity. Unless pricing, mix or cost structure improves, lower profitability can persist and constrain reinvestment, dividend capacity, and long‑term return recovery.
Weakened Cash GenerationOperating and free cash flow deterioration and poorer cash conversion point to working‑capital pressure or higher cash costs. Reduced cash reliability hampers the firm's ability to fund marketing, pay down debt, or absorb cost shocks, raising execution risk over the medium term.
Rising LeverageA material step-up in leverage increases financial rigidity and interest‑coverage sensitivity, especially while margins and cash flow are weakened. Higher debt heightens execution risk and reduces optionality for M&A or aggressive marketing until profitability and cash conversion recover.
Zydus Wellness Limited News
ZYDUSWELL FAQ
What was Zydus Wellness Limited’s price range in the past 12 months?
Zydus Wellness Limited lowest stock price was ₹357.55 and its highest was ₹552.40 in the past 12 months.
What is Zydus Wellness Limited’s market cap?
Zydus Wellness Limited’s market cap is ₹161.07B.
When is Zydus Wellness Limited’s upcoming earnings report date?
Zydus Wellness Limited’s upcoming earnings report date is Jul 31, 2026 which is in 47 days.
How were Zydus Wellness Limited’s earnings last quarter?
Zydus Wellness Limited released its earnings results on May 18, 2026. The company reported ₹5.1 earnings per share for the quarter, missing the consensus estimate of ₹5.133 by -₹0.033.
Is Zydus Wellness Limited overvalued?
According to Wall Street analysts Zydus Wellness Limited’s price is currently Overvalued.
Does Zydus Wellness Limited pay dividends?
Zydus Wellness Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.28%. See more information on Zydus Wellness Limited dividends here
What is Zydus Wellness Limited’s EPS estimate?
Zydus Wellness Limited’s EPS estimate is 4.3.
How many shares outstanding does Zydus Wellness Limited have?
Zydus Wellness Limited has 318,160,700 shares outstanding.
What happened to Zydus Wellness Limited’s price movement after its last earnings report?
Zydus Wellness Limited reported an EPS of ₹5.1 in its last earnings report, missing expectations of ₹5.133. Following the earnings report the stock price went down -1.097%.
Which hedge fund is a major shareholder of Zydus Wellness Limited?
Currently, no hedge funds are holding shares in IN:ZYDUSWELL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zydus Wellness Limited
Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free Natura, and Sugar Free Green. The company also offers well-known beverages like Complan, a milk-based health drink, and Glucon D, a glucose-infused refreshment, alongside Sugarlite, a unique blend of sugar and stevia. In the personal care segment, Zydus Wellness markets the Everyuth brand, featuring skincare items such as soap-free face washes, masks, scrubs, and cleansers. The Nycil brand provides solutions for prickly heat, cooling powders, and hand sanitizers. Furthermore, their Nutralite line includes a diverse array of spreads, from probiotic butter and table spreads to ghee, butter, cholesterol-fat-free spreads, mayonnaise, and chocolate spreads. Beyond its domestic operations in India, Zydus Wellness actively exports its offerings. Tracing its origins to 1988, the Ahmedabad, India-based entity was initially known as Carnation Nutra Analogue Foods Limited before adopting its current name, Zydus Wellness Limited, in January 2009. It operates as a subsidiary of Cadila Healthcare Limited.
Technical Analysis
Adani Wilmar Limited
―
Britannia Industries Ltd
―
Nestle India Ltd.
―
Patanjali Foods Limited
―
Tata Consumer Products Limited
―